Call For Editor-in-Chief

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Call for Editor in Chief 

Expert Review of Clinical Pharmacology

Deadline
18 February 2021

About the role

Expert Review of Clinical Pharmacology (2019 Impact Factor: 3.481) is currently looking for an Editor-in-Chief with an academic background in clinical pharmacology. The field of clinical pharmacology has never been more important; therefore, we are looking for someone with the enthusiasm and passion to drive the journal forward onto the next stage in its development within a rapidly evolving field. It is a significant role with a high profile, however one that can be taken on alongside managing a busy academic timetable.

The journal is part of Taylor & Francis’ Expert Collection and provides expert commentary and analysis on therapeutics and diagnostics in the field of clinical pharmacology. All manuscripts submitted to the journal are peer-reviewed in a double-blind fashion.  Coverage of the journal includes Medline-indexed clinical pharmacology research on drug evaluation, safety, toxicity, tolerability, efficacy, genomics, adverse reactions and pharmacoeconomics.

About the role

The successful candidate will spearhead the editorial board and work closely with the Commissioning Editor and Portfolio Manager on a regular basis. We are looking for someone who is enthusiastic about the journal, and willing to take on the following responsibilities:

  • Regularly advising the commissioning editor in ensuring the most relevant and up-to-date content is commissioned and covered in the journal, including suggesting topics and potential authors.
  • Representing the journal at conferences and networking events, where possible
  • Working alongside the Commissioning Editor and Portfolio Manager to strengthen and expand the current Editorial Board, including structuring the board into therapy areas.
  • Regularly submitting to the journal, where possible.

Occasionally, the Commissioning Editor may also request the Editor-in-Chief’s support in making final decisions on manuscripts that require further review. Sending invitations, dealing with any correspondence and all manuscript processing is done by the in-house editorial team.

In the future, there is scope for the role to develop to include assisting with assessing the suitability of Original Research papers submitted to the journal. Any change to responsibilities would be subject to consultation with the Editor-in-Chief.

Taylor & Francis will organise meetings twice a year to establish goals and plans for the journal, and we will supply annual reports reflecting on the performance of the journal. The journal utilises an online editorial office system, ScholarOne, in which training can be provided if needed.

 

 

Interested in applying? Here are the skills and attributes we would be looking for in a successful applicant:

  • Someone who is active in the clinical pharmacology community with strong personal networks and a publication record of at least 100 published papers
  • The ability to actively engage with authors and researchers to solicit the highest quality submissions on behalf of the journal
  • The ability to foster positive working relationships with the journal’s Commissioning Editor and Portfolio Manager
  • Regularly available and proactive in advising the Commissioning Editor of topics and areas of research to commission for the journal in order to increase readership
  • Willing to provide feedback, guidance, and support in the journal’s development and growth on a regular basis
  • A regular attendee/speaker at pharmacological conferences and willing to represent the journal at meetings and events

 

The role will formally begin in 2021

Submitting your Application

If you would like to apply for the position of Editor-in-Chief, please forward your CV, a covering letter, and a vision statement to Jermaine Wilcock, Commissioning Editor, and Shaunna Witters, Portfolio Manager. Your vision statement should be no longer than two pages and should cover:

  • Where you believe the field is going, and the journal’s place within it
  • How you would work in partnership with the editorial board
  • How you would maintain and increase the quality of submissions
  • How you would work with authors

 

Medline-indexed clinical pharmacology research on drug evaluation, safety, toxicity, tolerability, efficacy, genomics, adverse reactions and pharmacoeconomics.